Resistome Clinical Services published an article examining S. aureus bacteremia through a simple framework of detection, interpretation, decision, and clinical resolution.
Public source
Publisher name
Public post
🩸 A positive blood culture identifies the problem. It does not complete the management plan. When Staphylococcus aureus grows in blood, the most important work often be…
Company
Resistome Clinical Services
When antimicrobial decisions can’t wait
- Industry
- Medical Practices
- Location
- Ocean Isle Beach, US
- Company size
- 1 employee
About Resistome Clinical Services
Resistome Clinical Services is a pharmacist-led infectious diseases and antibiotic stewardship consultancy focused on turning complex microbiology and genomic data into clear, actionable clinical decisions. We specialize in rapid interpretation of molecular diagnostics, pathogen-specific resistance patterns, and difficult “bug–drug mismatch” cases where standard decision support tools fall short. Our work is designed to reduce delays, minimize unnecessary escalation to physician consults, and help frontline providers act with confidence—fast. What we do -Clinical interpretation of advanced microbiology and molecular diagnostic reports -Pathogen-focused antibiotic optimization and resistance analysis -Rapid, asynchronous consults with same-day or next-day turnaround -Support for hospitals, clinics, wound centers, and diagnostic laboratories How we’re different -Pharmacist-led, clinically grounded analysis -Clear, concise recommendations—no unnecessary jargon -Built for real-world workflows, not academic hypotheticals -Designed to complement (not replace) physician care teams When clinical decision support can’t wait, Resistome delivers clarity.
See moreLatest activity
Latest activity from Resistome Clinical Services
5 signals
Research & Knowledge
Resistome Clinical Services published a new study in Nature Communications explaining why antibiotic exposure alone does not determine bacterial killing, with a focus on structured Escherichia coli populations and fosfomycin.
Products & Services
Resistome Clinical Services brings together pharmacist-led infectious-disease interpretation and bioinformatics expertise to connect diagnostic findings with patient context and develop clinically defensible recommendations.
Presence & Recognition
Resistome Clinical Services is preparing a live presentation showing how complex infectious-disease diagnostic findings can be translated into actionable, patient-specific clinical recommendations.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
iFAST Diagnostics
iFAST Diagnostics published a peer-reviewed paper in the Journal of Clinical Microbiology titled “Multisite clinical evaluation of the iFAST rapid antimicrobial susceptibility test direct from positive blood cultures containing gram-negative organisms”
Research & Knowledge
Infectious Diseases Society of America
Infectious Diseases Society of America published a study in CID detailing the relationship between ID clinicians and pharmacists.
Research & Knowledge
BITSCOPIC
BITSCOPIC published a new study in Antimicrobial Stewardship & Healthcare Epidemiology highlighting the importance of antibiotic prescribing at hospital discharge and the metric designed to compare frequency and duration of oral antibiotics prescribed at discharge.
Research & Knowledge
P95
P95 published new research from the id.DRIVE Network examining 7,707 medically vulnerable adults hospitalized with severe acute respiratory infection (SARI) across 28 hospitals in five European countries.
Research & Knowledge
Global Antibiotic R&D Partnership (GARDP)